home / stock / pmxsf / pmxsf short
Short Information | Pharmaxis Ltd (OTCMKTS:PMXSF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 200,000 |
Total Actual Volume | 200,000 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 1 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 10,000 |
Average Short Percentage | 5.00% |
Is there a PMXSF Short Squeeze or Breakout about to happen?
See the PMXSF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
08-07-2020 | $0.0784 | $0.0784 | $0.0784 | $0.0784 | 200,000 | 200,000 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Pharmaxis Ltd Company Name:
PMXSF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips tells Proactive the company is set to undergo a restructure to refocus on developing drugs to treat blood-related cancers. This involves the creation of clinical stage drug development company, Syntara and the sale of its manni...
(NewsDirect) Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips speaks with Proactive after releasing data from a final interim analysis of 10 patients who have completed six months’ treatment with its drug PXS-5505 in an open label phase 2 clinical trial in patients with the bone ma...
(NewsDirect) Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips tells Proactive the company has made great progress towards commercialisation in a Phase 1C study of its topical Pan LOX inhibitor, achieving a well-tolerated safety profile and a marked change in scar composition. Importantly,...